Equities Research Analysts’ Downgrades for November 14th (ACAD, ADAP, ADC, ANSS, APEI, CSWI, CVS, CWEN, DOX, ESP)

Posted by on Nov 15th, 2024

Equities Research Analysts’ downgrades for Thursday, November 14th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Adaptimmune Therapeutics (NASDAQ:ADAP) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Agree Realty (NYSE:ADC) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

ANSYS (NASDAQ:ANSS) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

American Public Education (NASDAQ:APEI) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

CSW Industrials (NASDAQ:CSWI) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

CVS Health (NYSE:CVS) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Clearway Energy (NYSE:CWEN) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Amdocs (NASDAQ:DOX) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Espey Mfg. & Electronics (NYSEAMERICAN:ESP) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Hillenbrand (NYSE:HI) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

The InterGroup (NASDAQ:INTG) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Patrick Industries (NASDAQ:PATK) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Koninklijke Philips (NYSE:PHG) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Primerica (NYSE:PRI) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

RADCOM (NASDAQ:RDCM) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Sandstorm Gold (NYSE:SAND) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Receive News & Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.